Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs HAS✓SelectedUSD · HASGSK vs HAS performance historyLatest closeAs of-1.93%09/04
Stock and ETF performance explorer

GSK vs HAS

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,705.8%
HAS return
+3,598.5%
Excess return
-1,892.6%
Maximum drawdown
-55.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioHASExcessAlpha
1D-1.9%-0.5%-1.4%-1.8%
7D-1.8%-1.8%0.0%-1.5%
30D-2.2%+2.3%-4.4%-2.6%
3M-1.8%+10.4%-12.2%-3.5%
6M-10.6%-3.2%-7.4%-10.4%
YTD+4.4%+15.4%-11.0%+1.6%
1Y+30.4%+18.8%+11.6%+26.1%
3Y+60.1%+43.9%+16.1%+47.6%
5Y+46.8%+13.9%+32.9%+38.5%
10Y+79.2%+56.4%+22.8%+52.6%
All+1,705.8%+3,598.5%-1,892.6%+595.5%

Cumulative growth

Daily Returns

Daily percentage return beside HAS.

Daily Out/Under-Performance

Portfolio return minus HAS return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × HAS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded HAS wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling